These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32574317)

  • 1. Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.
    Chrzanowski W; Kim SY; McClements L
    Front Bioeng Biotechnol; 2020; 8():554. PubMed ID: 32574317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection.
    Bulut Ö; GÜrsel İ
    Turk J Biol; 2020; 44(3):273-282. PubMed ID: 32595362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
    Zhu Y; Geng S; Li Q; Jiang H
    Front Bioeng Biotechnol; 2020; 8():557652. PubMed ID: 33224928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.
    Kassem DH; Kamal MM
    Front Cell Dev Biol; 2020; 8():587866. PubMed ID: 33102489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Gardin C; Ferroni L; Chachques JC; Zavan B
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells-a literature review.
    Sachdeva K; Kumar A; Mohanty S
    Stem Cell Investig; 2021; 8():23. PubMed ID: 34917676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage.
    Pillalamarri N; Abdullah ; Ren G; Khan L; Ullah A; Jonnakuti S; Ullah M
    Transl Oncol; 2021 Jul; 14(7):101095. PubMed ID: 33887552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
    Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
    J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients.
    Csobonyeiova M; Smolinska V; Harsanyi S; Ivantysyn M; Klein M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research.
    Coelho A; Alvites RD; Branquinho MV; Guerreiro SG; Maurício AC
    Front Cell Dev Biol; 2020; 8():602647. PubMed ID: 33330498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations.
    Pironti G; Andersson DC; Lund LH
    Front Cell Dev Biol; 2021; 9():640723. PubMed ID: 33644077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2.
    Khandelwal V; Sharma T; Gupta S; Singh S; Sharma MK; Parashar D; Kashyap VK
    Mol Biol Rep; 2023 Mar; 50(3):2663-2683. PubMed ID: 36536185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases.
    Yang JH; Liu FX; Wang JH; Cheng M; Wang SF; Xu DH
    World J Stem Cells; 2020 Jul; 12(7):688-705. PubMed ID: 32843922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?
    Khalaj K; Figueira RL; Antounians L; Lauriti G; Zani A
    J Extracell Vesicles; 2020 Aug; 9(1):1795365. PubMed ID: 32944185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats.
    Dabrowska S; Andrzejewska A; Strzemecki D; Muraca M; Janowski M; Lukomska B
    J Neuroinflammation; 2019 Nov; 16(1):216. PubMed ID: 31722731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease.
    Gentile P; Sterodimas A; Pizzicannella J; Calabrese C; Garcovich S
    Aging Dis; 2020 Oct; 11(5):1191-1201. PubMed ID: 33014532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.
    Safari A; Lionetti V; Razeghian-Jahromi I
    Stem Cell Res Ther; 2021 Jul; 12(1):404. PubMed ID: 34266486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.